Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Net Medical Xpress Solutions, Inc. (NMXS)
Albuquerque, NM, US
Net Medical Xpress Solutions, Inc. specializes in delivering remote medical care solutions to a diverse range of healthcare institutions, including general and specialty hospitals, as well as nursing homes. The company offers services across various medical disciplines, such as remote neurology, neurosurgery, cardiology, orthopedics, wound care, and nephrology. Its technology portfolio includes the proprietary Telemed platform, designed to create tailored telemedicine management systems for its clientele. This platform is complemented by digital paper solutions, a powerful development engine, 'single pane of glass' software for consolidated views, and FDA-approved image viewing tools. Furthermore, it ensures seamless integration with over 43 hospital-based Electronic Medical Record (EMR) systems and supplies essential telemedicine video conferencing hardware along with USB clinical instruments. Beyond technology, Net Medical Xpress also supplies medical professionals and comprehensive administrative support, encompassing credentialing, program oversight, and call center operations. Additionally, it delivers integration services covering electronic prescription and prior authorization software, laboratory and malpractice insurance, extensive provider scheduling, medical translation, and patient rounding services. The company further extends its offerings to include staffing and recruitment, various diagnostic and clinical services, and Amazon cloud solutions. Initially established as New Mexico Software, Inc. in 1995, the organization adopted its current name, Net Medical Xpress Solutions, Inc., in January 2013. Its headquarters are located in Albuquerque, New Mexico.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +40.00% | +600.00% | +133.33% | -77.42% | -96.55% | -98.75% | -99.73% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%-88.5% Q1'24: -98.7% (vs Q1'23)
-
EPS growth Medical - Healthcare Information Services: +43.1%-309.8% Q1'24: +39.3% (vs Q1'23)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-118.6% Q1'24: -3,566.7% (vs Q1'23)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-303.9% Q1'24: -6,433.3% (vs Q1'23)
-
ROIC Medical - Healthcare Information Services: +5.2%-381.1% Q1'24: -203.2% (vs Q1'23)
-
Share dilution Medical - Healthcare Information Services: -0.1%+0.0% ★ Q1'24: +0.0% (vs Q1'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.56× Q1'24: -1.42× (vs Q1'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Teresa Dickey | Treasurer, Secretary & Director | 35.0K | female |
| Clara Jee | Head of Variant Detection Programs | — | — |
| Rafael Rubio | President | — | male |
| Yadira Ortiz | Chief Financial Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NMXS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
